- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 5/16 - Animal cells
Patent holdings for IPC class C12N 5/16
Total number of patents in this class: 1240
10-year publication summary
|
94
|
109
|
109
|
87
|
74
|
65
|
58
|
41
|
29
|
18
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 20842 |
16 |
| Regeneron Pharmaceuticals, Inc. | 4790 |
16 |
| F. Hoffmann-La Roche AG | 7800 |
14 |
| Amgen Inc. | 4436 |
13 |
| The Trustees of the University of Pennsylvania | 4432 |
11 |
| Dana-Farber Cancer Institute, Inc. | 2669 |
11 |
| The University of British Columbia | 1549 |
11 |
| Board of Regents, The University of Texas System | 6149 |
10 |
| CRISPR Therapeutics AG | 371 |
10 |
| Crystal Bioscience Inc. | 89 |
10 |
| Abbvie Inc. | 1799 |
9 |
| The Board of Trustees of the Leland Stanford Junior University | 6697 |
8 |
| CHO Plus, Inc. | 17 |
8 |
| Novartis AG | 10175 |
7 |
| Genentech, Inc. | 4119 |
7 |
| The Board of Trustees of the University of Illinois | 2753 |
7 |
| ImmunoGen, Inc. | 375 |
7 |
| Kyoto University | 2926 |
7 |
| Pierre Fabre Medicament | 518 |
7 |
| The Board of Regents of the University of Texas System | 2307 |
7 |
| Other owners | 1044 |